Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Funding Opportunities
Stephen I. Katz Early Stage Investigator Research Project Grant
PAR-24-075 (R01 - Clinical Trial Not Allowed)
PAR-24-076 (R01 - Basic Experimental Studies with Humans Required)
Expires December 29, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-25-074 (UH2/UH3, Clinical Trial Not Allowed)
PAR-25-075 (UH3, Clinical Trials Not Allowed)
Expires October 15, 2026
Impacts of Climate Change Across he Cancer Control Continuum
PAR-23-153 (R01 - Clinical Trial Optional) and PAR-23-152 (R21 - Clinical Trial Optional)
Expires May 8, 2026
Pragmatic Trials Across the Cancer Control Continuum
PAR-22-256 (UG3/UH3 - Clinical Trial Required)
Expires November 18, 2025
Investigator-Initiated Research in Genomics and Health Equity
RFA-HG-23-017 (R01 - Clinical Trial Optional)
Expires July 9, 2025
ClinGen Genomic Curation Expert Panels
PAR-23-199 (U24 - Clinical Trial Not Allowed)
Expires May 26, 2025
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
PAR-22-161 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Research Opportunities in Established Cancer Epidemiology Cohort Studies
PAR-22-162 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Notice of Special Interest: Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control
NOT-CA-25-004
Expires February 3, 2025
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues
NOT-OD-25-015
Expires January 24, 2025
Notice of Special Interest: Technology Development for Cancer Control and Population Science Research
NOT-CA-23-037
Expires December 31, 2024
Featured Event
Registration is now open!
The 2024 Cohort Consortium Annual Meeting will be held on November 12-15, 2024 at the NCI Shady Grove campus in Rockville, MD and will be a hybrid in-person/virtual format.
Featured Resource
Genomic Summary Results
Genomic summary results (GSR) serve as a valuable resource for cancer epidemiology researchers. Learn more about GSR, their significance in cancer epidemiology research, guidelines for sharing GSR data, and where such data can be accessed.
What's New
Connect With Us
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730
Follow Us on LinkedIn!
Are you interested in gaining access to funding opportunities, event information, and research insights from NCI’s Division of Cancer Control and Population Sciences (DCCPS)? We invite you to follow the DCCPS LinkedIn page.
Follow DCCPS